Filing Details
- Accession Number:
- 0000078003-19-000071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-19 16:19:11
- Reporting Period:
- 2019-09-17
- Accepted Time:
- 2019-09-19 16:19:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1773427 | Springworks Therapeutics Inc. | SWTX | Pharmaceutical Preparations (2834) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 78003 | Pfizer Inc | 235 E 42Nd St New York NY 10017 | No | No | Yes | No | |
| 1776087 | Pfizer Ventures (Us) Llc | 235 East 42Nd Street New York NY 10017 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-17 | 978,194 | $0.00 | 978,194 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-09-17 | 3,039,051 | $0.00 | 4,017,245 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-09-17 | 526,602 | $0.00 | 4,543,847 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-09-17 | 50,000 | $18.00 | 4,593,847 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Junior Series A Convertible Preferred Stock | Disposition | 2019-09-17 | 6,437,500 | $0.00 | 978,194 | $0.00 |
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2019-09-17 | 20,000,000 | $0.00 | 3,039,051 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2019-09-17 | 3,465,571 | $0.00 | 526,602 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Junior Series A Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 6.5810:1 basis upon the closing of the Issuer's initial public offering for no additional consideration. The Junior Series A Convertible Preferred Stock had no expiration date. Such shares are held of record by Pfizer Inc. ("Pfizer").
- Each share of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 6.5810:1 basis upon the closing of the Issuer's initial public offering for no additional consideration. The Series A Convertible Preferred Stock had no expiration date. Such shares are held of record by Pfizer.
- Each share of Series B Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 6.5810:1 basis upon the closing of the Issuer's initial public offering for no additional consideration. The Series B Convertible Preferred Stock had no expiration date. Such shares are held of record by Pfizer Ventures (US) LLC, a wholly-owned subsidiary of Pfizer ("PVUS").
- PVUS purchased such additional shares of Common Stock in the Issuer's initial public offering at the initial public offering price of $18.00 per share.
- Each Reporting Person disclaims ownership of securities held by the other Reporting Person, except to the extent of its pecuniary interest therein.
Billionaire Hedge Funds
